Point taken about execution failure.
But the design is fine.
Open label means that patients don't have to worry about being on placebo.
The two dosage levels means that patients can choose which they prefer.
The problems are that EMD AML is a very rare disease, and sites other than Newcastle haven't appeared.
General Comments / Chat, page-7684
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.56 |
Change
0.020(1.30%) |
Mkt cap ! $265.8M | |||
| Open | High | Low | Value | Volume |
| $1.60 | $1.60 | $1.56 | $62.86K | 40.08K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1113 | $1.53 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.57 | 2300 | 1 |
View Market Depth
| Last trade - 10.48am 10/10/2024 (20 minute delay) ? |
| RAC (ASX) Chart |